🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

If you want to know more about our European Prevention of Alzheimer’s disease cohort collaboration ✨Euro-PAD✨ or want to find out how to join, then come and find me today at poster #37! 🧠 Alzheimer Europe Alzheimer's Disease Data Initiative AMYPAD #AAIC24

#AAIC24 started this morning with an interactive educational session on Amyloid PET Quantification. Thanks to all speakers & delegates🤗 👉Today stop by Poster 88788 from Dr Emma Luckett "Associations between AD polygenic risk scores & global amyloid deposition in AMYPAD"

New study out revealing distinct genetic risk profiles in association with specific pathophysiological aspects in predementia stages of Alzheimer's disease with EPAD data! Congrats to Luigi Lorenzini and all authors👏 doi.org/10.1002/alz.14…

So thrilled to see our Imaging-genetics paper finally out in A&D!! And even more that this is happening during an amazing AAIC, were we first presented these results last year. ... 🎈 alz-journals.onlinelibrary.wiley.com/doi/10.1002/al…

Want something to carry your #AAIC24 materials in? Come by booth 1224 to answer these questions and receive a free tote! - What are you most optimistic about in the #ADRD research space? - What's the biggest barrier in #Alzheimer’s research today?

Want to know more about the NeuroToolKit Application developed by Roche Diagnostics & supported by Alzheimer's Disease Data Initiative? Check out this paper reporting its testing phase & how this tool could advance research in Alzheimer's disease⤵️ Craig Ritchie Juando Gispert ncbi.nlm.nih.gov/pmc/articles/P…

🧠September is World Alzheimer’s Month, an international campaign to raise #dementia awareness and challenge stigma. 🌍Follow along with #WorldAlzMonth! ADI #TimeToActOnDementia #TimeToActOnAlzheimers

The data, bio samples & neuroimaging generated from the EPAD study are available for researchers studying the brain & neurodegenerative diseases. Visit our website for further information⤵️ ep-ad.org #TimeToActOnDementia #TimeToActOnAlzheimers #WorldAlzMonth

Happy to see this out after long time and effort we put into it! Important collaborative work where we examined the interrelationship between systemic vascular factors, cerebrovascular disease and AD pathological changes in non-demented individuals ... neurology.org/doi/10.1212/WN…

For #WorldAlzMonth, we're pleased to present our new EPAD paper published in Neurology Journal. Congratulations Luigi Lorenzini & team👋 neurology.org/doi/10.1212/WN…

Today is #WorldAlzheimerDay 🧠 Every 3 seconds someone in the world develops #dementia and there are over 55 million people around the world living with dementia🌍 #WorldAlzMonth #TimeToActOnDementia #TimeToActOnAlzheimers

We had a fantastic day yesterday at the EU-MIND Congress! If you're attending #EUMind2024, don’t miss Lyduine Collij's presentation today on 'From AMYPAD to #EuroPAD – creating a multi-cohort preclinical database to model AD disease trajectories.' #EUMIND

The EPAD biobank includes blood, CSF, saliva and urine samples collected over the course of our longitudinal study. Interested in applying for sample access? Visit our website: ep-ad.org #TimeToActOnDementia #TimeToActOnAlzheimers #WorldAlzMonth

So nice to hear Elisabetta Vaudano presenting the neurodegeneration portfolio from Innovative Health Initiative at #34AEC. Alzheimer Europe is involved in many of these projects, contributing through communication & public involvement activities and ethics discussions.

✨New Interview with Dr Emma Luckett, Postdoc Researcher & Data Manager at the Department of Radiology/Nuclear Medicine at the Amsterdam UMC. Don't miss this interview where she shares her AMYPAD work & what inspires her the most about research. amypad.eu/news/recent-ne…

Check out this new paper "Cerebral Microbleeds and Amyloid Pathology Estimates From the Amyloid Biomarker Study" using data from 15 research and memory clinic studies including EPAD Congratulations to all authors👏 jamanetwork.com/journals/jaman…

👉Check out this new paper assessing longitudinal brain atrophy and cognitive decline as a function of cerebrospinal fluid (CSF) AD biomarkers in the ALFA and EPAD cohorts! Congratulations to all authors 👏 Raffaele Cacciaglia alz-journals.onlinelibrary.wiley.com/doi/10.1002/al…

📢New paper out perfoming a well-powered Brain Wide Association Study of the grey-matter structure in Alzheimer's disease, symptoms and progression, using a meta-analysis across 11 Cohorts including EPAD ⤵️ onlinelibrary.wiley.com/doi/10.1002/hb…

📢 New paper out aiming to better inform use of Parental Onset of Dementia (POD) as a risk stratification tool in studies of late-onset Alzheimer's disease. Congratulations to all authors 👍 alz-journals.onlinelibrary.wiley.com/doi/full/10.10…

👉Welcome to Day 2 of #ADPD2025! We're pleased that several oral presentations mentioned the EPAD project yesterday! Interested to know more about our data? Stop by booth 16 of Alzheimer's Disease Data Initiative to see demos of #ADWorkbench! ep-ad.org/index.php/2025…